Both transfusion and anaemia in the perioperative period are associated with increased risk to the patient. With the advent of patient blood management programmes, we are reminded that the clinical strategies to avoid blood transfusion should be multidisciplinary, begin preoperatively and involve every stage of the patient pathway.
The decision to transfuse a patient during the perioperative period should always be made on a case-by-case basis. There is a balance of risk between anaemia and transfusion. Anaemia is associated with increased risks of perioperative mortality and morbidity, infectious complications, prolonged hospitalization and a greater likelihood of transfusion. Traditionally, a haemoglobin measurement of 10 g/dl was considered to be an appropriate transfusion threshold, based on studies of rheology and oxygen delivery, rather than outcome data. Current guidelines 1 suggest it is safe to lower this threshold to 8 g/dl, even in patients with cardiorespiratory disease. 2 The risks of transfusion are well understood and rare ( Figure 1 ). A total of 3038 events were reported to the UK Serious Hazards of Transfusion (SHOT) in 2011. 3 Table 1 below shows the more common events of the 1815 analysed by SHOT. There were no transfusion-transmitted infections reported to the 2011 SHOT group with the risk now less than one in a million. Reports of an association between long-term survival following cardiac surgery and transfusion indicate that transfusion may have more risk associated with it than was previously thought. 4 Our understanding that risks are associated with both anaemia and transfusion make it particularly important that we use all possible clinical strategies available to avoid them.
Patient blood management (PBM)
PBM is the application of evidence-based medical and surgical concepts designed to:
optimize the patient's haemoglobin minimize blood loss and bleeding optimize the patient's physiology to tolerate anaemia. These strategies are multidisciplinary, multimodal and individualized and are being gradually introduced throughout Europe. They can be divided into those used by the pre-operative assessment clinic (POAC), those used intra-operatively either by the anaesthetist, the surgeon or another member of the theatre team and those used during the post-operative period. 5 Preoperative techniques to avoid transfusion (Table 2) POAC and multidisciplinary team (MDT) meetings The role of the POAC is not only to investigate but also correct any anaemia. Iron, vitamin B 12 and folate deficiencies should all be corrected before major elective surgery. Erythropoietin, used in combination with iron, is successful in raising the haemoglobin concentration prior to surgery, thus reducing the need for transfusion. Assessment of bleeding risk may favour temporarily discontinuing oral anticoagulation (aspirin, clopidogrel etc.) but the implications of this should be discussed at the POAC.
Preoperative autologous donation is a technique whereby the patient undergoes weekly blood donations of up to 10 ml/kg. Iron and erythropoietin are used to speed recovery of red cell mass between donations, prior to surgery. However, the National Blood Service in the UK does not offer this service as it is expensive, time consuming, increases requirement for autologous blood transfusion and the risk of transfusion error is not reduced.
MDT meetings enable discussion about the correct approach to surgery. This should include feasibility of minimally invasive above open surgery (e.g. open aortic aneurysm repair vs. endovascular repair) or staging procedures (e.g. corrective spinal surgery performed in two stages, allowing recovery from anaemia in between). The decision to use a larger operating team, thus reducing the duration of surgery, may also be taken.
Intraoperative strategies to avoid transfusion (Table 3) Although some of the strategies used in the operating room are the domain of the anaesthetist (e.g. controlled hypotension) and some are specific to the surgeon (e.g. meticulous haemostasis), there are several techniques where responsibility is less clear and a team approach is important (e.g. the use of cell salvage).
Patient positioning
Blood loss can be minimized with attention to positioning, particularly when the patient is placed in the prone position.
Learning objectives
After reading this article you should be able to: Pelvic and chest supports reduce pressure on and enhance flow through the inferior vena cava, with less passing through the vertebral venous plexuses. Bleeding is reduced in radical prostate surgery using hyperextension of the back so that the legs and heart are lower than the operative site.
Ventilation
Minimizing mean intrathoracic pressure during controlled ventilation with minimal use of positive end-expiratory pressure and low tidal volumes increases venous return, leading to reduced blood loss.
Controlled hypotension
An accepted definition of controlled hypotension is a mean arterial pressure (MAP) of 50 mmHg, based on estimates of adequate cerebral perfusion pressure in the healthy population. It was originally used as a technique to improve the operative field, but evidence has emerged showing it leads to a reduced need for blood transfusion in hip, spinal and open prostate surgery. Numerous pharmacological methods have been described including neuroaxial blockade, inhalational anaesthetics, intravenous b-blockers (esmolol), a-blockers (phentolamine), calcium channel blockers (diltiazem) and direct arterial or venous vasodilators (glyceryl trinitrate or sodium nitroprusside). If controlled hypotension is employed, invasive arterial monitoring should be used as standard. Contraindications to this technique include coronary artery disease, poorly controlled hypertension, cerebrovascular disease and anaemia.
Antifibrinolytic agents
Tranexamic acid is widely used to reduce bleeding in orthopaedic and cardiac surgery. Aprotinin was licensed for patients undergoing cardiac surgery but the licence was suspended when a study suggested that the risks of complications outweighed the benefits of reduced bleeding. Following a review of the study and other literature the European Medicines Agency has recently (2012) recommended that the suspension be lifted.
Percentage of events by category reported in the Serious Hazards of Transfusion (SHOT) annual report 2008 (n = 1040)
IBCT (262) ADE (137) ATR (300) TRALI (17) HTR (55) PTP (1) TAGVH (0) TTI (6) HSE (139) TACO (18) TAD (1) AT (28) I&U (76) Figure 1 Most common causes of reports to SHOT 
Acute normovolaemic haemodilution
This technique involves withdrawing approximately 450 ml of blood into a standard blood bag containing citrate, phosphate, dextrose and adenine with simultaneous infusion of colloid to maintain normovolaemia. This is usually repeated three times, depending on the initial haematocrit. Reduction in need for blood transfusion relies on the fact that there is reduced red cell loss intra-operatively. The blood is then reinfused at the end of the operation. This reinfusion should be supervised by the anaesthetist involved in the initial harvesting, as the usual checking procedures for administering this blood are not applicable.
Cell salvage
This technique relies on a combination of a reservoir for collection of aspirated, shed blood and a centrifugal system to wash and concentrate the blood. Blood is anticoagulated as it is aspirated, either with heparin or with a solution of acidecitrateedextrose.
With an adequate volume in the reservoir, the blood is then centrifuged to concentrate the red cells and washed with normal saline. The resulting product is concentrated red cells with no clotting factors or platelets and a haematocrit of approximately 55%. Cell salvage is indicated for operations when the expected blood loss is 20% or more of the estimated total blood volume or when more than 10% of patients undergoing the procedure require a transfusion. The list of contraindications to cell salvage is extensive and certainly includes the use of anything that will cause cell lysis in the reservoir (sterile water, hydrogen peroxide, alcohol). Many centres use cell salvage for obstetric and cancer surgery because despite previous concerns, there is little evidence to indicate that reinfusion of small amounts of amniotic fluid or malignant cells is harmful.
Avoidance of hypothermia
Hypothermia will render the patient hypocoagulable due to effects on enzyme function within the coagulation cascade. Any allogenic blood transfused intra-operatively should be warmed prior to transfusion, in keeping with the NICE guidance on management of inadvertent perioperative hypothermia. 6 Postoperative strategies to avoid transfusion (Table 4) Reinfusion of blood from wound drains Blood may be collected from wound drains before being treated and reinfused. Treatment may be simple filtration prior to reinfusion which is commonly used in orthopaedics and is considered safe if the volume is less than a litre and the process is completed in less than 6 hours. Some centres use centrifuged and washed wound blood from mediastinal shed blood following cardiac surgery, but this is a more complex procedure.
Transfusion threshold
The most significant factor in avoiding transfusion over the past 10 years is due to education of doctors that a reduced transfusion threshold is safe. Recent evidence demonstrates that a liberal transfusion strategy (a higher haemoglobin threshold of 10 g/dl) did not improve outcomes compared to a restrictive strategy (haemoglobin threshold of <8 g/dl) in a population of high-risk patients. 
